Genetic reduction of Adm results in enhanced cardiovascular damage including increased cardiac hypertrophy in male Adm+/- mice [81] and marked perivascular fibrosis, coronary artery intimal hyperplasia and oxidative stress with AngII/high-salt treatment [32]. The gene discussed is ADM; the disease is cardiac hypertrophy.